These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9507929)

  • 1. Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil.
    Engber TM; Koury EJ; Dennis SA; Miller MS; Contreras PC; Bhat RV
    Neurosci Lett; 1998 Jan; 241(2-3):95-8. PubMed ID: 9507929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.
    Lin JS; Hou Y; Jouvet M
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14128-33. PubMed ID: 8943072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine.
    Engber TM; Dennis SA; Jones BE; Miller MS; Contreras PC
    Neuroscience; 1998 Dec; 87(4):905-11. PubMed ID: 9759978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic arousal regions are activated during modafinil-induced wakefulness.
    Scammell TE; Estabrooke IV; McCarthy MT; Chemelli RM; Yanagisawa M; Miller MS; Saper CB
    J Neurosci; 2000 Nov; 20(22):8620-8. PubMed ID: 11069971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain pattern of histone H3 phosphorylation after acute amphetamine administration: its relationship to brain c-fos induction is strongly dependent on the particular brain area.
    Rotllant D; Armario A
    Neuropharmacology; 2012 Feb; 62(2):1073-81. PubMed ID: 22063717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates.
    Willie JT; Renthal W; Chemelli RM; Miller MS; Scammell TE; Yanagisawa M; Sinton CM
    Neuroscience; 2005; 130(4):983-95. PubMed ID: 15652995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Armodafinil promotes wakefulness and activates Fos in rat brain.
    Fiocchi EM; Lin YG; Aimone L; Gruner JA; Flood DG
    Pharmacol Biochem Behav; 2009 May; 92(3):549-57. PubMed ID: 19249327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The brain pattern of c-fos induction by two doses of amphetamine suggests different brain processing pathways and minor contribution of behavioural traits.
    Rotllant D; Márquez C; Nadal R; Armario A
    Neuroscience; 2010 Jul; 168(3):691-705. PubMed ID: 20406670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression.
    Ferraro L; Fuxe K; Tanganelli S; Tomasini MC; Rambert FA; Antonelli T
    J Neurosci Res; 2002 Apr; 68(1):107-12. PubMed ID: 11933055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of stress and amphetamine administration on Fos-like protein expression in corticotropin releasing factor-neurons of the rat brain.
    Rotllant D; Nadal R; Armario A
    Dev Neurobiol; 2007 May; 67(6):702-14. PubMed ID: 17443818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat.
    Touret M; Sallanon-Moulin M; Jouvet M
    Neurosci Lett; 1995 Apr; 189(1):43-6. PubMed ID: 7603622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The central nucleus of the amygdala and the wake-promoting effects of modafinil.
    Silvestri AJ; Sanford LD; Ross RJ; Mann GL; Pavlock A; Morrison AR
    Brain Res; 2002 Jun; 941(1-2):43-52. PubMed ID: 12031546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated amphetamine administration induces Fos in prefrontal cortical neurons that project to the lateral hypothalamus but not the nucleus accumbens or basolateral amygdala.
    Morshedi MM; Meredith GE
    Psychopharmacology (Berl); 2008 Apr; 197(2):179-89. PubMed ID: 18080115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine sensitization augments amphetamine-induced Fos expression in the lateral habenula.
    Hamamura T; Ichimaru Y
    Brain Res; 1997 Aug; 767(1):140-3. PubMed ID: 9365026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of modafinil and d-amphetamine in male Sprague-Dawley rats trained to discriminate d-amphetamine.
    Quisenberry AJ; Prisinzano T; Baker LE
    Pharmacol Biochem Behav; 2013 Sep; 110():208-15. PubMed ID: 23880213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.
    Lin JS; Roussel B; Akaoka H; Fort P; Debilly G; Jouvet M
    Brain Res; 1992 Sep; 591(2):319-26. PubMed ID: 1359924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neural substrates of amphetamine conditioned place preference: implications for the formation of conditioned stimulus-reward associations.
    Rademacher DJ; Kovacs B; Shen F; Napier TC; Meredith GE
    Eur J Neurosci; 2006 Oct; 24(7):2089-97. PubMed ID: 17067306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretin activates visceral brain regions in the rat including areas abnormal in autism.
    Welch MG; Keune JD; Welch-Horan TB; Anwar N; Anwar M; Ruggiero DA
    Cell Mol Neurobiol; 2003 Oct; 23(4-5):817-37. PubMed ID: 14514034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats.
    Ishizuka T; Murakami M; Yamatodani A
    Eur J Pharmacol; 2008 Jan; 578(2-3):209-15. PubMed ID: 17920581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat.
    Gozzi A; Colavito V; Seke Etet PF; Montanari D; Fiorini S; Tambalo S; Bifone A; Zucconi GG; Bentivoglio M
    Neuropsychopharmacology; 2012 Feb; 37(3):822-37. PubMed ID: 22048464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.